Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases

  • Rodríguez-Sinovas, Cristina
  • Martínez-González, José
  • Raposo, Berta
  • Alcudia, Javier F.
  • Guadall, Anna
  • Badimón Maestro, Lina
Lysyl oxidase (LOX) plays a crucial role in the maintenance of extracellular matrix stability and could participate in vascular remodelling associated with cardiovascular diseases. Evidence from in vitro and in vivo studies shows that LOX downregulation is associated with the endothelial dysfunction characteristic of earlier stages of the atherosclerotic process. Conversely, upregulation of this enzyme in vascular cells could induce neointimal thickening in atherosclerosis and restenosis. In fact, LOX is chemotactic for vascular smooth muscle cells and monocytes, is modulated by proliferative stimulus in these cells, and could control other cellular processes such as gene expression and cell transformation. Furthermore, it is conceivable that LOX downregulation could underlie plaque instability and contribute to the destructive remodelling that takes place during aneurysm development. Overall, LOX could play a key role in vascular homeostasis and, hence, it emerges as a new player in cardiovascular diseases. This review addresses the experimental evidence related to the role of LOX in vascular disorders and the potential benefits of controlling its expression and function., The original work was supported by grants from Fondo de Investigaciones Sanitarias (PI061480); Ministerio de Educación y Ciencia (SAF 2006-07378, SAF 2006-10091); CIBER-OBENU 06/03; and Red Temática de Investigación Cardiovascular (RECAVA)-Instituto de Salud Carlos III (RD06/0014/0027)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors

  • Rodríguez-Sinovas, Cristina
  • Alcudia, Javier F.
  • Martínez-González, José
  • Guadall, Anna
  • Raposo, Berta
  • Sánchez-Gómez, Sonia
  • Badimón Maestro, Lina
Statins are lipid-lowering drugs widely used in the management of vascular diseases. Clinical and experimental evidence suggest that statins improve endothelial function by both cholesterol-lowering-dependent and -independent mechanisms. We have previously shown that endothelial dysfunction induced by risk factors and proinflammatory cytokines is associated with down-regulation of lysyl oxidase (LOX), a key enzyme modulating extracellular matrix maturation and vascular integrity. Our aim was to analyse whether statins could normalize LOX expression impaired by proatherogenic risk factors., This work was supported by Sociedad Española de Cardiología (SEC); Fondo de Investigaciones Sanitarias [FIS061480]; Red Temática de Investigación Cardiovascular RECAVA [RD06/0014/0027] from Instituto de Salud Carlos III; and Ministerio de Educación y Ciencia [SAF2006-07378, SAF2006-10009]., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation

  • Orbe, Josune
  • Rodríguez, José Antonio
  • Calvayrac, Olivier
  • Rodríguez-Calvo, R.
  • Rodríguez, C.
  • Roncal Mancho, Carmen
  • Martínez de Lizarrondo, Sara
  • Barrenetxe, Jaione
  • Reverter, Juan Carlos
  • Martínez-González, José
  • Páramo, José A.
Objective: thrombin is a multifunctional serine protease that promotes vascular proinflammatory responses whose effect on endothelial MMP-10 expression has not previously been evaluated. Methods and Results: thrombin induced endothelial MMP-10 mRNA and protein levels, through a protease-activated receptor-1 (PAR-1)–dependent mechanism, in a dose- and time-dependent manner. This effect was mimicked by a PAR-1 agonist peptide (TRAP-1) and antagonized by an anti–PAR-1 blocking antibody. MMP-10 induction was dependent on extracellular regulated kinase1/2 (ERK1/2) and c-jun N-terminal kinase (JNK) pathways. By serial deletion analysis, site-directed mutagenesis and electrophoretic mobility shift assay an AP-1 site in the proximal region of MMP-10 promoter was found to be critical for thrombin-induced MMP-10 transcriptional activity. Thrombin and TRAP-1 upregulated MMP-10 in murine endothelial cells in culture and in vivo in mouse aorta. This effect of thrombin was not observed in PAR-1–deficient mice. Interestingly, circulating MMP-10 levels (P<0.01) were augmented in patients with endothelial activation associated with high (disseminated intravascular coagulation) and moderate (previous acute myocardial infarction) systemic thrombin generation. Conclusion: thrombin induces MMP-10 through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Endothelial MMP-10 upregulation could be regarded as a new proinflammatory effect of thrombin whose pathological consequences in thrombin-related disorders and plaque stability deserve further investigation., This work was funded through the 'UTE project CIMA' (University of Navarra), Ministerio de Sanidad y Consumo (FIS/PI050777 and FIS/PI061480), Ministerio de Educación y Ciencia (SAF2006-07378 and SAF2009-12039), Departamento de Salud, Gobierno de Navarra (39/2004), and Red Temática de Investigación Cardiovascular RECAVA (RD06/0014/0008 and RD06/0014/0027).